Exploring Three High Growth Tech Stocks in Hong Kong

In This Article:

As global markets navigate a complex landscape, with the Hang Seng Index recently experiencing a decline amid broader economic shifts in China, the spotlight turns to high-growth tech opportunities in Hong Kong. In this dynamic environment, identifying stocks with robust innovation potential and adaptability to changing market conditions can be key for investors seeking growth.

Top 10 High Growth Tech Companies In Hong Kong

Name

Revenue Growth

Earnings Growth

Growth Rating

Wasion Holdings

22.37%

25.47%

★★★★★☆

MedSci Healthcare Holdings

48.74%

48.78%

★★★★★☆

Inspur Digital Enterprise Technology

23.28%

38.77%

★★★★★☆

RemeGen

26.23%

52.03%

★★★★★☆

Innovent Biologics

22.11%

59.31%

★★★★★☆

Akeso

33.50%

53.12%

★★★★★★

Cowell e Holdings

31.68%

35.44%

★★★★★★

Biocytogen Pharmaceuticals (Beijing)

21.53%

109.17%

★★★★★☆

Beijing Airdoc Technology

37.47%

93.35%

★★★★★☆

Sichuan Kelun-Biotech Biopharmaceutical

24.70%

8.53%

★★★★★☆

Click here to see the full list of 43 stocks from our SEHK High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

BOE Varitronix

Simply Wall St Growth Rating: ★★★★☆☆

Overview: BOE Varitronix Limited is an investment holding company that designs, manufactures, and sells liquid crystal displays and related products across various international markets, with a market cap of approximately HK$4.50 billion.

Operations: The company generates revenue primarily from the design, manufacture, and sale of liquid crystal displays and related products, amounting to HK$11.71 billion. The business operates in multiple international markets including China, Europe, the United States, and Korea.

BOE Varitronix, amidst a challenging landscape marked by a 16.7% dip in past earnings, still projects robust growth with earnings expected to surge by 21.3% annually, outpacing the Hong Kong market's 12.1%. This optimism is fueled by its substantial R&D commitment, which not only underscores innovation but also aligns with an anticipated revenue increase of 14.1% per year—double the local market average of 7.4%. Recent financials reveal a mixed scenario: while H1 sales rose to HKD 6.16 billion from HKD 5.21 billion year-over-year, net income slightly retracted to HKD 172.1 million from HKD 202.51 million, reflecting both resilience and areas for improvement in operational efficiency and market adaptation strategies. Despite these hurdles, BOE Varitronix's strategic investments in research and development could catalyze future technological advancements and customer acquisition within Hong Kong’s tech sector—a critical factor as it navigates through current profitability challenges and aims for sustained long-term growth.